U.S. federal trademark · Serial No. 50136150
Printed educational course materials in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed magazine columns about hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed general feature magazines in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed magazines in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed materials, namely, journals featuring hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed journals in the field of hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed informational flyers featuring hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Printed diagrams for hypertrophic cardiomyopathy and other thick-hearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis
Promoting public awareness of hypertrophic cardiomyopathy and other thickhearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Promoting public interest and awareness of hypertrophic cardiomyopathy and other thickhearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Charitable services, namely, promoting public awareness of hypertrophic cardiomyopathy and other thickhearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis; Arranging and conducting of volunteer programs and community service projects for charitable purposes; Promoting collaboration within the scientific, research and provider communities to achieve advances in the field of hypertrophic cardiomyopathy and other thickhearted disorders including Danon disease, Fabry disease, cardiac amyloidosis, Pompe disease, Friedrich’s ataxia, RASopathies, PRKAG2, mitochondrial diseases, and cardiac sarcoidosis
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.